Literature DB >> 24012198

A tumor necrosis factor-α inhibitor reduces the embryotoxic effects of endometriotic peritoneal fluid.

Yi-Jen Chen1, Hua-Hsi Wu, Wan-Ting Liau, Chang-Youh Tsai, Hsiao-Wen Tsai, Kuan-Chong Chao, Yen-Jen Sung, Hsin-Yang Li.   

Abstract

OBJECTIVE: To determine whether a tumor necrosis factor-α (TNF-α) inhibitor can reduce the embryotoxicity of the peritoneal fluid (PF) of women with endometriosis.
DESIGN: Experimental clinical study.
SETTING: University hospital. PATIENT(S): Twelve women with chocolate cysts and 12 control women without endometriosis. INTERVENTION(S): None. MAIN OUTCOME MEASURE(S): We collected the PF from patients with chocolate cysts (CH-PF) and patients without endometriosis (N-PF) during laparoscopic surgery. For the in vitro studies, development and apoptosis were evaluated in two-cell stage mouse embryos after incubation with CH-PF and N-PF, with or without a TNF-α inhibitor. RESULT(S): We found that CH-PF significantly decreased the rate of blastocyst development and increased the percentage of apoptotic cells in the embryos. Cytokine assays showed that the concentrations of several cytokines, including TNF-α, were higher in embryos incubated with CH-PF than in those incubated with N-PF. Furthermore, the treatment of embryos with TNF-α retarded development and induced apoptosis. Important, adalimumab, a TNF-α inhibitor, effectively abrogated the embryotoxicity that was induced by CH-PF. CONCLUSION(S): These data collectively highlight the crucial role of TNF-α in CH-PF-induced embryotoxicity and suggest that TNF-α inhibitors may be potential therapeutic agents for treating endometriosis-induced infertility.
Copyright © 2013 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  TNF-α; embryotoxicity; endometriosis; peritoneal fluid

Mesh:

Substances:

Year:  2013        PMID: 24012198     DOI: 10.1016/j.fertnstert.2013.07.1985

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  7 in total

Review 1.  Endometriosis: where are we and where are we going?

Authors:  Alexis D Greene; Stephanie A Lang; Jessica A Kendziorski; Julie M Sroga-Rios; Thomas J Herzog; Katherine A Burns
Journal:  Reproduction       Date:  2016-05-10       Impact factor: 3.906

Review 2.  Mouse is the new woman? Translational research in reproductive immunology.

Authors:  David A Clark
Journal:  Semin Immunopathol       Date:  2016-01-18       Impact factor: 9.623

Review 3.  Role of inflammation in benign gynecologic disorders: from pathogenesis to novel therapies†.

Authors:  Abdelrahman AlAshqar; Lauren Reschke; Gregory W Kirschen; Mostafa A Borahay
Journal:  Biol Reprod       Date:  2021-07-02       Impact factor: 4.285

Review 4.  Implications of immune dysfunction on endometriosis associated infertility.

Authors:  Jessica E Miller; Soo Hyun Ahn; Stephany P Monsanto; Kasra Khalaj; Madhuri Koti; Chandrakant Tayade
Journal:  Oncotarget       Date:  2017-01-24

5.  Integrated analysis of mRNA and protein expression profiling in tubal endometriosis.

Authors:  Hang Qi; Huiyu Zhang; Xiaoya Zhao; Ya Qin; Guiling Liang; Xiaoqing He; Jian Zhang
Journal:  Reproduction       Date:  2020-05       Impact factor: 3.906

6.  Identification of endometriosis-associated genes and pathways based on bioinformatic analysis.

Authors:  Ting Wang; Ruoan Jiang; Yingsha Yao; Linhua Qian; Yu Zhao; Xiufeng Huang
Journal:  Medicine (Baltimore)       Date:  2021-07-09       Impact factor: 1.817

Review 7.  Antirheumatic drugs and reproduction in women and men with chronic arthritis.

Authors:  Chiara Bazzani; Laura Andreoli; Michele Agosti; Cecilia Nalli; Angela Tincani
Journal:  RMD Open       Date:  2015-08-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.